DaShenLin Pharmaceutical Group Co., Ltd.

XSSC:603233 Stock Report

Market Cap: CN¥17.4b

DaShenLin Pharmaceutical Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Guoqiang Ke

Chief executive officer

CN¥2.3m

Total compensation

CEO salary percentagen/a
CEO tenure5.8yrs
CEO ownership0.02%
Management average tenureno data
Board average tenure1.8yrs

Recent management updates

Recent updates

CEO

Guoqiang Ke (42 yo)

5.8yrs

Tenure

CN¥2,308,800

Compensation

Mr. Guoqiang Ke is General Manager of DaShenLin Pharmaceutical Group Co., Ltd. from February 28, 2019 and serves as DIrector since February 03, 2023. He was Deputy General Manager of DaShenLin Pharmaceutic...

Board Members

NamePositionTenureCompensationOwnership
Guoqiang Ke
GM & Director1.8yrsCN¥2.31m0.025%
CN¥ 4.3m
Qun Fei Tan
Deputy GM & Director1.8yrsCN¥2.05m0.024%
CN¥ 4.1m
Zhi Hui Chen
Chairman of Supervisory Board & Deputy Director of Human Resources Department - Guangdong Provinceno datano data0.012%
CN¥ 2.1m
Yun Feng Ke
Chairman of the Boardno dataCN¥2.49m21.3%
CN¥ 3.7b
Guo Liu
Independent Directorno dataCN¥73.40kno data
Zu Yao Su
Independent Directorno dataCN¥80.00kno data
Jie Li
Directorno datano datano data
Li Ping Lu
Independent Directorno dataCN¥80.00kno data
Jinshu Shi
Staff Supervisorno datano data0.00055%
CN¥ 95.8k
Wensheng Chen
Supervisor1.8yrsno datano data

1.8yrs

Average Tenure

54yo

Average Age

Experienced Board: 603233's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.